Company research / GOVX

GeoVax Labs, Inc. (GOVX)

CIK 0000832489 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, GeoVax Labs, Inc. reported revenue of $2.49M. Revenue fell 37.1% from the prior annual period.

Key ratios (year ended 2025-12-31)

-869.3%
Operating margin
-862.3%
Net margin
-561.2%
Return on year-end equity
-37.1%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-08-28

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.